Reuters logo
BRIEF-Dova Pharmaceuticals announces New Drug Application submission to FDA
September 22, 2017 / 11:08 AM / a month ago

BRIEF-Dova Pharmaceuticals announces New Drug Application submission to FDA

Sept 22 (Reuters) - Dova Pharmaceuticals Inc

* Dova Pharmaceuticals announces New Drug Application submission to FDA for avatrombopag, a second generation thrombopoietin receptor agonist

* Dova Pharmaceuticals Inc - ‍in both trials, avatrombopag met primary and secondary efficacy endpoints with high statistical significance​

* Dova pharmaceuticals inc - ‍submission of a New Drug Application to U.S. Food and Drug Administration for avatrombopag​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below